Skip to main content
logo
Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden flag Sweden · Delayed Price · Currency is SEK
24.65
-0.70 (-2.76%)
May 22, 2026, 5:29 PM CET

Xspray Pharma AB Revenue

Xspray Pharma AB had revenue of 2.47M SEK in the twelve months ending March 31, 2026. In the year 2025, Xspray Pharma AB had annual revenue of 2.47M.

Revenue
2.47M
Revenue Growth
n/a
P/S Ratio
473.97
Revenue / Employee
102.75K
Employees
24
Market Cap
1.17B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.47M--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Saniona AB434.40M
Cantargia AB317.21M
BioInvent International AB217.86M
Genovis AB (publ.)131.09M
Oncopeptides AB83.24M
Corline Biomedical AB10.66M
Medivir AB9.01M
Flerie AB1.80M
Revenue Rankings

Xspray Pharma AB News

More News